c/o A & E Planning Co., Ltd. Hitotsubashi Bekkan 4F, 2-4-4 Hitotsubashi, Chiyoda-ku, Tokyo 101-0003Tel: +81-3-3230-2744 Fax: +81-3-3230-2479 E-mail: [email protected]
Inquiries: AsCNP2019 SecretariatInquiries: AsCNP2019 SecretariatInquiries: AsCNP2019 Secretariat
AsCNP6th Congress of
Chair: Reiji Yoshimura(University of Occupational and Environmental Health)
Chair: Hisatsugu Miyata (Jikei University School of Medicine)
Chair: Reiji Yoshimura(University of Occupational and Environmental Health
29th Annual Meeting of Japanese Society of Clinical Neuropsychopharmacology
JSCNPChair: Chair: Hisatsugu Miyata Jikei University School of MedicineJikei University School of Medicine)University of Occupational and Environmental Health)
Chair: (Jikei University School of Medicine
Clinical Neuropsychopharmacology
49th Annual Meeting of Japanese Society of Neuropsychopharmacology
JSNPJoint Annual Meetings
Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science)
Vice Chairs: Kazutaka Shimoda (Dokkyo Medical University)
Toshiyuki Someya (Niigata University)
Secretary: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science)
October 11-13, 2019Fukuoka International Congress CenterFukuoka Sunpalace Hotel & HallFukuoka, Japan
Asian College of NeuropsychopharmacologyNeuropsychopharmacology to the next generation:
New wave from Asia
Late-breaking Abstract Submission: July 1(Mon) - 31(Wed), 2019
AsCNP2019 Websitehttps://www2.aeplan.co.jp/ascnp/
Greetings
It is our great pleasure to organize the 6th Asian College of Neuropsychopharmacology (AsCNP) Congress that will be held in Fukuoka, Japan, on October 11-13, 2019. The main theme of the congress is “Neuropsychopharmacology to the next generation: New wave from Asia.” Pharmacotherapy for the treatment of neuropsychiatric disorders should be developed further in Asia where robust economic expansion has occurred. Most medications for the treatment of central nervous system disorders have been developed for the European and American populations but are not always suitable for Asian populations. Medications should be developed specifically for Asians, including appropriate dosage and usage. The AsCNP2019 Congress seeks to advance neuropsychopharmacology to the next generation in Asia.
AsCNP was founded in 2008, based on the need to elucidate the mechanisms that underlie the effects of medications for the treatment of central nervous system disorders, develop new medications, and appropriately utilize such medications in Asia. The mission of AsCNP is to encourage research, facilitate the communication of ideas in converging disciplines of neuropsychopharmacology in Asia, develop pharmacotherapies for the treatment for psychiatric disorders, provide education and training opportunities, and empower patients and their families with scientific knowledge. The AsCNP Congress was convened in Kyoto in 2009, Seoul in 2011, Beijing in 2013, Taipei in 2015, and Bali in 2017. AsCNP currently has more than 3000 members.
The AsCNP2019 Congress will be held in conjunction with the annual meetings of the Japanese Society of Neuropsychopharmacology (JSNP) and Japanese Society of Clinical Neuropsychopharmacology (JSCNP). Other AsCNP member societies are also planning joint events at the AsCNP2019 Congress. Many scientists, clinicians, industry researchers, governmental officials, and invited world-renowned leaders will gather at the congress to advance neuropsychopharmacology in Asia.We look forward to welcoming you in Fukuoka in 2019.
Neuropsychopharmacology to the next generation:New wave from Asia
Congress Information
Period
6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)October 11 (Fri) – 13 (Sun), 2019
Joint Annual Meetings:29th Annual Meeting of Japanese Society of Clinical Neuropsychopharmacology (JSCNP2019)October 11 (Fri), 12 (Sat), 2019
49th Annual Meeting of Japanese Society of Neuropsychopharmacology (JSNP2019)October 12 (Sat), 13 (Sun), 2019
Venue
Fukuoka International Congress Center (2-1 Sekijo-machi, Hakata-ku, Fukuoka City 812-0032, TEL:092-262-4111)
Fukuoka Sunpalace Hotel and Hall(2-1, Chikko Hon-machi, Hakata-ku, Fukuoka City 812-0021, TEL: 092-272-1123)
Theme
Neuropsychopharmacology to the next generation: New wave from Asia
Expected Number of Participants
2,000 (total number of participants of the three meetings)
Host
Asian College of Neuropsychopharmacology (AsCNP)
Supporting Organizations
Fukuoka City / The International College of Neuropsychopharmacology / Japanese Association of Cardiovascular Pharmacology / Japan Epilepsy Society / Japanese Medical Society of Alcohol and Addiction Studies / The Japanese Neuropsychiatric Association / Japan Neuroscience Society / Japan Pharmaceutical Association / Japan Pharmaceutical Manufacturers Association / The Japanese Pharmacological Society / The Physiological Society of Japan / Japan Psychiatric Hospitals Association / The Japanese Society for Neurochemistry / Japanese Society of Biological Psychiatry / The Japanese Society of
6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) 1
Asian College of Neuropsychopharmacology
2 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)
Clinical Pharmacology and Therapeutics / Japanese Society of Hospital Pharmacists / Japanese Society of General Hospital Psychiatry / Japanese Society of Neurology / Japanese Society of Mood Disorders / Japan Society of Pain Clinicians / Japanese Society for Psychiatric Diagnosis / The Japanese Society of Psychiatry and Neurology / Japanese Society of Schizophrenia Research / Japanese Society of Sleep Research / Japan Tourism Agency / The Kyushu Association of Neuropsychiatry / Kyushu Psychiatric Hospitals Association / The Molecular Biology Society of Japan / Union of Brain Science Associations in Japan
Organizers
Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science)Vice Chairs: Kazutaka Shimoda (Dokkyo Medical University) Toshiyuki Someya (Niigata University)Alliance Head: Hiroyuki Uchida (Keio University) Secretary: Shinya Kasai (Tokyo Metropolitan Institute of Medical Science)
Organizing Committee Chair: Shigenobu Kanba (Kyushu Univeristy)Organizing Committee Members:
Tatsuo Akechi Satoshi Asakura Masato Asanuma Hazime Baba Won-Myong Bahk Ya-Mei Bai Haruhiko Bito Eric Yu Hai Chen Shigeru Chiba Lih-Chu Chiou Yuan-Hwa Chou Young-Chul Chung Brian Dean Nagafumi Doi Ken-ichi Fukuda Masato Fukuda Kohji Fukunaga Toshiaki A. Furukawa Tomoyuki Furuyashiki Hitoshi Hashimoto Kenji Hashimoto Ryota Hashimoto Nobutaka Hattori Yanling He Teruhiko Higuchi Hirokazu Hirai Masayuki Hiramatsu Yoshio Hirayasu Naoyuki Hironaka Hikaru Hori Jun Horiguchi Hiroshi Ichinose Jun-ichi Iga Kazutaka Ikeda Manabu Ikeda Masashi Ikeda Toshiya Inada Ataru Inagaki Koki Inoue Takeshi Inoue Masako Iseki Yasushi Ishida Kumiko Ishige Jun Ishigooka Takeshi Ishihara Masanari Itokawa Akira Iwanami Katsunori Iwasaki Nakao Iwata Nobuhisa Iwata Masaomi Iyo Hiroshi Kadotani Mitsuhiro Kamata Yasuhiro Kaneda Shuji Kaneko Kosuke Kanemoto Kiyoto Kasai Masaki Kato Nobumasa Kato Tadafumi Kato Chiaki Kawanishi Hiroaki Kawasaki Satoshi Kida Tetsuro Kikuchi Toshiaki Kikuchi Chan-Hyung Kim Euitae Kim Toshihiko Kinoshita Taro Kishi Taishiro Kishimoto Toshifumi Kishimoto Kiyoyuki Kitaichi Kazuto Kobayashi Fumitoshi Kodaka Tsuyoshi Koide Shuichi Koizumi Tsuyoshi Kondo Tsukasa Koyama Hiroaki Kumano Hiroshi Kunugi Toshihide Kuroki Ichiro Kusumi Jun Soo Kwon Shih-Ku Lin Tetsuya Matsuda Kenji Matsumoto Hisato Matsunaga Kazuo Mihara Roumen Milev Masaru Mimura Kyung Joon Min Masabumi Minami Itaru Miura Masatomo Miura Tsuyoshi Miyakawa Hitoshi Miyaoka
Neuropsychopharmacology to the next generation:New wave from Asia
6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) 3
Hisatsugu Miyata Hirokazu Mizoguchi Akira Monji Hisashi Mori Shigeru Morinobu Norimitsu Morioka Toshiya Murai Mitsukuni Murasaki Hiroshi Nagase Shin Nakagawa Kazuyuki Nakagome Jun Nakamura Yu Nakamura Yoshihiro Nakata Minoru Narita Akinori Nishi Naoki Nishiguchi Toru Nishikawa Katsuji Nishimura Gentarou Nishioka Atsumi Nitta Shin-Ichi Niwa Yukihiro Noda Yasuyuki Nomura Shusuke Numata Tetsuro Ohmori Yukihiro Ohno Toshihisa Ohtsuka Motohiro Okada Hitoshi Okamoto Yasumasa Okamoto Hitoshi Okazawa Yoshiro Okubo Gaku Okugawa Hisae Ono Noriko Osumi Koichi Otani Kyohei Otani Tempei Otsubo Kotaro Otsuka Norio Ozaki Hiroki Ozawa Yuji Ozeki Naren P. Rao Tadashi Saigusa Manabu Saito Takuya Saito Toshikazu Saito Akira Sano Junji Saruwatari Masashi Sasa Masamichi Sato Mitsumoto Sato Yasushi Sato Winston W. Shen Eiji Shimizu Kazutaka Shimoda Takahiro Shinkai Kazuhiro Shinosaki Osamu Shirakawa Yukihiko Shirayama Tianme Si Toshiyuki Someya Ichiro Sora Tung-Ping Su Shiro Suda Norio Sugawara Tetsuya Suhara Tomiki Sumiyoshi Suresh Sundram Akihito Suzuki Michio Suzuki Takefumi Suzuki Tsutomu Suzuki Yutaro Suzuki Kohji Takada Hiroyuki Takagi Kazuo Takahama Hidehiko Takahashi Ryosuke Takahashi Masatoshi Takeda Yoshiteru Takekita Kazuhiro Takuma Toru Takumi Chay Hoon Tan Andi Jayalangkara Tanra Takeshi Terao Shogo Tokuyama Hiroaki Tomita Tetsu Tomita Makoto Tsuda Hiroyuki Uchida Naohisa Uchimura Yosuke Uchitomi Shu-ichi Ueno Yasuhito Uezono Koichiro Watanabe Norio Watanabe Shigeru Watanabe Takashi Watanabe Hirooki Yabe Kazuo Yamada Kiyofumi Yamada Mitsuhiko Yamada Norihito Yamada Shigeki Yamaguchi Hidenori Yamasue Shigeto Yamawaki Kazuhiko Yanai Yen-Kung Yang Norio Yasui-Furukori Setsuko Yasukawa Hiroshi Yoneda Yukio Yoneda Takeo Yoshikawa Masafumi Yoshimura Reiji Yoshimura Takashi Yoshio Mitsuhiro Yoshioka Xin Yu Kunio Yui Gang Zhu
Program Committee Chair: Ryota Hashimoto (National Center of Neurology and Psychiatry)Program Committee Members:
Kazutaka Ikeda Shinya Kasai Chan-Hyung Kim Fumitoshi Kodaka Shih-Ku Lin Roumen Milev Tsuyoshi Miyakawa Hisatsugu Miyata Tetsuo Nakabayashi Atsumi Nitta Naren P. Rao Kazutaka Shimoda Takahiro Shinkai Toshiyuki Someya Tung-Ping Su Suresh Sundram Chay Hoon Tan Andi Jayalangkara Tanra Hiroyuki Uchida Shigeto Yamawaki Reiji Yoshimura Xin Yu
Asian College of Neuropsychopharmacology
Special LectureAsCNP Special Lecture
October 11 (Fri) 15 : 20 ~ 16 : 20Masayo TadaSumitomo Dainippon Pharma Co., Ltd.
October 12 (Sat) 8 : 40 ~ 10 : 20Allan Young Lakshmi YathamKing’s College London UK
University of British Columbia Canada
October 12 (Sat) 13 : 40 ~ 14 : 40George F. KoobNational Institute on Alcohol Abuse and AlcoholismUSA
October 13 (Sun) 13 : 40 ~ 14 : 40Hailan HuZhejiang University School of Medicine China
October 13 (Sun) 14 : 50 ~ 16 : 30John M. Kane Herbert Y. MeltzerThe Zucker Hillside Hospital USA
Northwestern Feinberg School of Medicine USA
4 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)
Neuropsychopharmacology to the next generation:New wave from Asia
6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) 5
JSNP/JSCNP Special Lecture
October 12 (Sat) 13 : 40 ~ 14 : 40Shigenobu KanbaKyushu UniversityJapan
※ Japanese Session
JSNP Special Lecture
October 13 (Sun) 13 : 40 ~ 14 : 40Edward F. DominoUniversity of MichiganUSA
JSCNP Special Lecture
October 11 (Fri) 15 : 20 ~ 16 : 20Toshiyuki SomeyaNiigata University Japan
※ Japanese Session
October 11 (Fri) 16 : 30 ~ 18 : 10Bernhard T. Baune Andrea FagioliniUniversity of MünsterGermany
University of Siena School of MedicineItaly
6 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)
Day1: October 11 (Fri) *Tentative Schedule as of July, 2019
Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00
Opening Ceremony
Set Up
8:00
Maintenance treatment following remitted
�rst episode psychosis
Yu-Hai, Eric Chen
JSCNPSymposium
JSCNPSymposium
JSCNPSymposium
JSCNPSymposium
Developing new pharmaceutical
agents for unmet medical needs in schizophrenia - From preclinical
to clinical studiesWen-Sung Lai
JSCNPSymposium
JSCNPSymposium
JSCNPOral Presentation
JSCNPOral Presentation
A cutting-edge view on how to
regulate the drug dependence
related behaviors
Tomohisa Mori
Neurobiology of endocannabinoid
system in psychiatric disorders
Hiroki Ishiguro
Recent Advances in Autism
Research from Asia
Atsushi Sato
Novel treatment strategies based on the
advanced understanding of neurobiological
mechanisms in obsessive-compulsive
spectrum disorderHisato
Matsunaga
What can we learn from brain imaging studies
of schizophrenia? From its
pathophysiology to actual treatment Hiroyuki Uchida
Cellular and molecular signatures of
psychiatric disorders in postmortem human brainShinya Kasai
AsCNPOral Presentation
9:00 9:00
10:00 10:00
Translation of Research to Clinical Practice
Roumen Milev
JSCNPSymposium
JSCNPSymposium
JSCNPSymposium
JSCNPSymposium
Novel antidepressant targets found
from the central serotonergic and related systems
Mitsuhiro Yoshioka
The multidimensional
approach to metabolic
disturbance in schizophrenia
Mong-Liang Lu
JSCNPOral Presentation
JSCNPOral Presentation
JSCNPOral Presentation
Community Care and Global Mental Health:
innovative psychiatric
pharmacotherapy strategies in Asia
Chieko Kurihara
The Global Collection Initiative
for psychiatric genetics From
genetic variation to disease
mechanismsYasue Horiuchi
Novel strategy to treat hallucinations and
delusions in schizophrenia: searching for new targets
in neural circuits and brain networks
Kazuyuki Nakagome
Sponsored Symposium
Eisai Co., Ltd.
Stresses and psychiatric diseases ~mechanisms,
gender, treatment~Atsumi Nitta
AsCNPOral Presentation
Poster Exhibition
11:00 11:00
12:00 12:00
Luncheon Seminar
H. Lundbeck
Luncheon SeminarOtsuka
Pharmaceutical Co., Ltd.
Luncheon SeminarDaiichi Sankyo
Co., Ltd. / UCB Japan Co. Ltd.
Luncheon SeminarSumitomo Dainippon
Pharma Co., Ltd.
Luncheon SeminarMitsubishi
Tanabe Pharma Corporation.
13:00 13:00
JSCNP Award Lecture
Poster Discussion
14:00 14:00
JSCNP General Assembly & Council Committee15:00 15:00
Set up for Social Gathering
16:00 16:00
JSCNP Special Lecture
Speaker: Bernhard T.
Baune Andrea Fagiolini
Chair: Reiji Yoshimura
Sponsored Symposium
Janssen Pharmaceutical
K.K.
JSCNPSymposium
JSCNPSymposium
Sponsored SymposiumSHIONOGI &
CO., LTD. / Takeda
Pharmaceutical Company Limited.
Clinical research of gut-
microbiota-brain axis
Chun-Hsin Chen
Advances in animal
models of drug addiction
Soichiro Ide
JSCNPOral Presentation
JSCNPOral Presentation
JSCNPOral Presentation
Sponsored Symposium
Otsuka Pharmaceutical
Co., Ltd.
Future Development of Biomarker
in Mental disorders
Andi Jayalangkara
Tanra
International neuroimaging
big data collaborations:
ENIGMA and COCORO
Ryota Hashimoto
17:00 17:00
18:00 18:00
AsCNP/JSNP/JSCNP
Joint SocialGathering
19:00 19:00
20:00 20:00
AsCNP Special Lecture
Speaker: Masayo Tada Chair: Jun Soo Kwon
Program at a Glance
E J J J J E J J J
E
E
J
J
E
E
J J
J
J
J
J
J
J
E E J
J
J
JE E
8:40
10:20
12:10
15:20
16:20
18:10
12:30 12:30
13:30 13:30
6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) 7
Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00
Opening Ceremony
Set Up
8:00
Maintenance treatment following remitted
�rst episode psychosis
Yu-Hai, Eric Chen
JSCNPSymposium
JSCNPSymposium
JSCNPSymposium
JSCNPSymposium
Developing new pharmaceutical
agents for unmet medical needs in schizophrenia - From preclinical
to clinical studiesWen-Sung Lai
JSCNPSymposium
JSCNPSymposium
JSCNPOral Presentation
JSCNPOral Presentation
A cutting-edge view on how to
regulate the drug dependence
related behaviors
Tomohisa Mori
Neurobiology of endocannabinoid
system in psychiatric disorders
Hiroki Ishiguro
Recent Advances in Autism
Research from Asia
Atsushi Sato
Novel treatment strategies based on the
advanced understanding of neurobiological
mechanisms in obsessive-compulsive
spectrum disorderHisato
Matsunaga
What can we learn from brain imaging studies
of schizophrenia? From its
pathophysiology to actual treatment Hiroyuki Uchida
Cellular and molecular signatures of
psychiatric disorders in postmortem human brainShinya Kasai
AsCNPOral Presentation
9:00 9:00
10:00 10:00
Translation of Research to Clinical Practice
Roumen Milev
JSCNPSymposium
JSCNPSymposium
JSCNPSymposium
JSCNPSymposium
Novel antidepressant targets found
from the central serotonergic and related systems
Mitsuhiro Yoshioka
The multidimensional
approach to metabolic
disturbance in schizophrenia
Mong-Liang Lu
JSCNPOral Presentation
JSCNPOral Presentation
JSCNPOral Presentation
Community Care and Global Mental Health:
innovative psychiatric
pharmacotherapy strategies in Asia
Chieko Kurihara
The Global Collection Initiative
for psychiatric genetics From
genetic variation to disease
mechanismsYasue Horiuchi
Novel strategy to treat hallucinations and
delusions in schizophrenia: searching for new targets
in neural circuits and brain networks
Kazuyuki Nakagome
Sponsored Symposium
Eisai Co., Ltd.
Stresses and psychiatric diseases ~mechanisms,
gender, treatment~Atsumi Nitta
AsCNPOral Presentation
Poster Exhibition
11:00 11:00
12:00 12:00
Luncheon Seminar
H. Lundbeck
Luncheon SeminarOtsuka
Pharmaceutical Co., Ltd.
Luncheon SeminarDaiichi Sankyo
Co., Ltd. / UCB Japan Co. Ltd.
Luncheon SeminarSumitomo Dainippon
Pharma Co., Ltd.
Luncheon SeminarMitsubishi
Tanabe Pharma Corporation.
13:00 13:00
JSCNP Award Lecture
Poster Discussion
14:00 14:00
JSCNP General Assembly & Council Committee15:00 15:00
Set up for Social Gathering
16:00 16:00
JSCNP Special Lecture
Speaker: Bernhard T.
Baune Andrea Fagiolini
Chair: Reiji Yoshimura
Sponsored Symposium
Janssen Pharmaceutical
K.K.
JSCNPSymposium
JSCNPSymposium
Sponsored SymposiumSHIONOGI &
CO., LTD. / Takeda
Pharmaceutical Company Limited.
Clinical research of gut-
microbiota-brain axis
Chun-Hsin Chen
Advances in animal
models of drug addiction
Soichiro Ide
JSCNPOral Presentation
JSCNPOral Presentation
JSCNPOral Presentation
Sponsored Symposium
Otsuka Pharmaceutical
Co., Ltd.
Future Development of Biomarker
in Mental disorders
Andi Jayalangkara
Tanra
International neuroimaging
big data collaborations:
ENIGMA and COCORO
Ryota Hashimoto
17:00 17:00
18:00 18:00
AsCNP/JSNP/JSCNP
Joint SocialGathering
19:00 19:00
20:00 20:00
The di�erent e�ects of ketamine and its enantiomers
on chronic stress induced- depressed animal models and
clinical antidepressant and anti-suicidal e�ect studies in acute and maintenance therapy of patients with
treatment resistant depressionTung-Ping Su Luncheon Seminar
Pfizer Japan Inc. / Sumitomo Dainippon Pharma Co., Ltd.
JSCNPSpecial Lecture
Speaker: Toshiyuki Someya Chair: Tsuyoshi Kondo
AsCNP Session JSNP/JSCNP Session JSNP Session JSCNP Session Sponsored Session
J : Japanese E : English
J E E E E E E E
J
J
J
E JJ
J
J
E
E
E E E E E E
E E
12:30
13:3013:40
14:30
15:10 15:10
18:20
15:20
16:20
13:40
8 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)
Day2: October 12 (Sat)Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00
Set Up
8:00
AsCNPSpecial Lecture
Speaker: Allan Young
Lakshmi Yatham
JSNP-JSCNP Joint Workshop
JSNP-JSCNP Joint Symposium
JSNPSymposium
JSCNPSymposium
Translational Research for
New Drug Development in Neuropsychiatric
DisordersToshitaka
Nabeshima
JSCNPSymposium
JSNPOral
PresentationJSCNP
SymposiumJSCNP
Oral Presentation
Molecular Pathology and
Therapeutic Potentials in
SchizophreniaTetsuro Ohmori
Perspectives on psychiatric research from
an Asian-Paci�c context
Suresh Sundram
Sponsored Symposium
Philip Morris Japan Ltd. / Japan
Tobacco Inc. / British American
Tobacco Japan, Ltd.
Brain Stimulation on
Neuropsychiatric Disorders: Basic
Mechanisms and Clinical E�cacyCheng-Ta Li
Early detection and new intervention in
psychiatric disorders: from rare diseases, schizophrenia, to
dementiaNorio Ozaki
Imaging genetics of
schizophreniaJinsong Tang
AsCNPOral
Presentation
9:00 9:00
10:00 10:00
Regulatory Collaboration to Accelerate
Drug Development
Junko Sato Tetsuo
Nakabayashi
JSCNP SeminarJSNP-
JSCNP Joint Symposium
JSNPSymposium
JSCNPSymposium
Sponsored Symposium
Otsuka Pharmaceutical
Co., Ltd.
JSNPSymposium
JSNPOral
Presentation
JSCNPOral
Presentation
JSCNPOral
Presentation
Sponsored Symposium
Chugai Pharmaceutical
Co., Ltd.
The habenular nuclei involved
in emotional regulation
Hitoshi Hashimoto
Sponsored SymposiumSumitomo Dainippon
Pharma Co., Ltd.
Research on Asian
Psychotropic prescription
pattern (REAP)Shih-Ku Lin
Network meta-analysis, Individual
participant (network) meta-analysis & Cumulative
(network) meta-analysis
Toshi Furukawa
Glia-Psycho-Pathology:
Findings from Rodent Models
to Human Subjects
Takahiro Kato
Neuropsychopharmacology of relaxin-3
Gavin Stewart Dawe
Poster Exhibition
11:00 11:00
12:00 12:00
Luncheon SeminarSumitomo Dainippon
Pharma Co., Ltd
Luncheon SeminarOtsuka
Pharmaceutical Co., Ltd
Luncheon SeminarEli Lilly Japan
K.K. / SHIONOGI & CO., LTD.
Luncheon SeminarTeijin Pharma
Limited.
Luncheon SeminarNippon
Shinyaku Co., Ltd.
Luncheon SeminarPhilip Morris
Japan Ltd.
Luncheon SeminarEisai Co., Ltd.
Luncheon SeminarH. Lundbeck13:00 13:00
AsCNPSpecial Lecture
Speaker: George F. Koob
14:00 14:00
AsCNP/AMEDSymposium
Makoto Suematsu
Shigeo OkabeJSCNP Seminar
JSNP-JSCNP Joint Symposium
JSNPSymposium
JSNPSymposium
Early Career Researchers Symposium
Clinical research in progress
on addictive medicine
Toshikazu Saito
JSNPSymposium
JSNPSymposium
JSCNPOral
Presentation
JSCNPOral
Presentation
Obsessive-compulsive
disorder: clinical heterogeneity and innovative
treatment approaches
Chan-Hyung Kim
Unveiling the neuro-cognitive underpinnings
of schizophrenia: From clinical
application to conceptual analysis
Yen-Kuang Yang
Ketamine: From Abused
Drug to Rapid-Acting
AntidepressantKenji
Hashimoto
Emerging roles of DAMPs/alarmins
and PRRs in neurological
disordersAtsufumi Kawabata
Understanding the pathophysiology of
psychiatric disorders: Japan / Australia
collaborations using tissue from the
Melbourne Brain Bank Brian Dean
AsCNPOral
Presentation
AsCNPOral
Presentation
15:00 15:00
16:00 16:00
PosterDiscussion
17:00 17:00
18:00 18:00
Evening Mixer with
Cheese & Wine
19:00 19:00
20:00 20:00
E J J J J E J J J
E
E
J
J
E
J
J
J
J
J
J
J
J
E
JJ
J
J
J
J
J
J
8:40
10:20
12:10
J
E
14:50
16:50
14:40
13:40
12:30
13:30
6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) 9
Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00
Set Up
8:00
AsCNPSpecial Lecture
Speaker: Allan Young
Lakshmi Yatham
JSNP-JSCNP Joint Workshop
JSNP-JSCNP Joint Symposium
JSNPSymposium
JSCNPSymposium
Translational Research for
New Drug Development in Neuropsychiatric
DisordersToshitaka
Nabeshima
JSCNPSymposium
JSNPOral
PresentationJSCNP
SymposiumJSCNP
Oral Presentation
Molecular Pathology and
Therapeutic Potentials in
SchizophreniaTetsuro Ohmori
Perspectives on psychiatric research from
an Asian-Paci�c context
Suresh Sundram
Sponsored Symposium
Philip Morris Japan Ltd. / Japan
Tobacco Inc. / British American
Tobacco Japan, Ltd.
Brain Stimulation on
Neuropsychiatric Disorders: Basic
Mechanisms and Clinical E�cacyCheng-Ta Li
Early detection and new intervention in
psychiatric disorders: from rare diseases, schizophrenia, to
dementiaNorio Ozaki
Imaging genetics of
schizophreniaJinsong Tang
AsCNPOral
Presentation
9:00 9:00
10:00 10:00
Regulatory Collaboration to Accelerate
Drug Development
Junko Sato Tetsuo
Nakabayashi
JSCNP SeminarJSNP-
JSCNP Joint Symposium
JSNPSymposium
JSCNPSymposium
Sponsored Symposium
Otsuka Pharmaceutical
Co., Ltd.
JSNPSymposium
JSNPOral
Presentation
JSCNPOral
Presentation
JSCNPOral
Presentation
Sponsored Symposium
Chugai Pharmaceutical
Co., Ltd.
The habenular nuclei involved
in emotional regulation
Hitoshi Hashimoto
Sponsored SymposiumSumitomo Dainippon
Pharma Co., Ltd.
Research on Asian
Psychotropic prescription
pattern (REAP)Shih-Ku Lin
Network meta-analysis, Individual
participant (network) meta-analysis & Cumulative
(network) meta-analysis
Toshi Furukawa
Glia-Psycho-Pathology:
Findings from Rodent Models
to Human Subjects
Takahiro Kato
Neuropsychopharmacology of relaxin-3
Gavin Stewart Dawe
Poster Exhibition
11:00 11:00
12:00 12:00
Luncheon SeminarSumitomo Dainippon
Pharma Co., Ltd
Luncheon SeminarOtsuka
Pharmaceutical Co., Ltd
Luncheon SeminarEli Lilly Japan
K.K. / SHIONOGI & CO., LTD.
Luncheon SeminarTeijin Pharma
Limited.
Luncheon SeminarNippon
Shinyaku Co., Ltd.
Luncheon SeminarPhilip Morris
Japan Ltd.
Luncheon SeminarEisai Co., Ltd.
Luncheon SeminarH. Lundbeck13:00 13:00
AsCNPSpecial Lecture
Speaker: George F. Koob
14:00 14:00
AsCNP/AMEDSymposium
Makoto Suematsu
Shigeo OkabeJSCNP Seminar
JSNP-JSCNP Joint Symposium
JSNPSymposium
JSNPSymposium
Early Career Researchers Symposium
Clinical research in progress
on addictive medicine
Toshikazu Saito
JSNPSymposium
JSNPSymposium
JSCNPOral
Presentation
JSCNPOral
Presentation
Obsessive-compulsive
disorder: clinical heterogeneity and innovative
treatment approaches
Chan-Hyung Kim
Unveiling the neuro-cognitive underpinnings
of schizophrenia: From clinical
application to conceptual analysis
Yen-Kuang Yang
Ketamine: From Abused
Drug to Rapid-Acting
AntidepressantKenji
Hashimoto
Emerging roles of DAMPs/alarmins
and PRRs in neurological
disordersAtsufumi Kawabata
Understanding the pathophysiology of
psychiatric disorders: Japan / Australia
collaborations using tissue from the
Melbourne Brain Bank Brian Dean
AsCNPOral
Presentation
AsCNPOral
Presentation
15:00 15:00
16:00 16:00
PosterDiscussion
17:00 17:00
18:00 18:00
Evening Mixer with
Cheese & Wine
19:00 19:00
20:00 20:00
JSNP-JSCNP Joint sessionSpecial Lecture
Speaker: Shigenobu Kanba Chairs: Hisatsugu Miyata
Reiji Yoshimura
Luncheon SeminarKYOWA Pharmaceutical
Industry Co., Ltd. / Yoshitomiyakuhin
Corporation
AsCNP Session JSNP/JSCNP Session JSNP Session JSCNP Session Sponsored Session
J : Japanese E : English
J E E E E E E E
J
J
E
E
J
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
J
12:30
13:40
12:30
16:40
18:10
13:30
14:40
13:30
10 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)
Day3: October 13 (Sun)Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00
Set Up
8:00
JSNP General Assembly
Noteworthy drug discovery/
research and development - Aiming for innovation -
Tetsurou Kikuchi
JSNPSymposium
EGUIDE workshop
Cognitive impairments,
neuroimaging and genetics in chronic methamphetamine users and ketamine
usersYanhui Liao
New development of
Research in Asian Psychotropic
Drug Prescription
(REAP)ChayHoon Tan
The multidimensional
approach to treatment
response in major depression
Po-Hsiu Kuo
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
Sponsored Symposium
Japan Tobacco Inc.
Dementia-In�ammation
and PropagationTetsuaki Arai
Translational Research regarding
pharmacological treatment of
ADHD Masanori Isobe
AsCNPAward Lecture
9:00 9:00
10:00 10:00
JSNP Seminar
CINP Symposium - Current and future
management of major depressive
disorder: challenges and perspectives -
Siegfried Kasper
Sponsored Symposium
Janssen Pharmaceutical
K.K.
Psychostimulant Addiction and
Psychosis: Human Brain Imaging and
Rodent StudiesJin-Chung
Chen
Basic and Translational Research in
EpilepsyZhong Chen
Neuroimmune Mechanisms of Mood Disorder: A Translational
PerspectivePo See Chen
JSNPSymposium
JSNPSymposium
AsCNPOral Session
AsCNPAward Lecture
JSNPSymposium
Sponsored Symposium
Japan Tobacco Inc.
New frontier of bio-
markers and therapeutics in
DementiaKohji
Fukunaga
JSNPSymposium
Multifaceted Roles of Orexins:
Sleep, Pain and Reward Regulations
Lih-Chu Chiou
Poster Exhibition
11:00 11:00
12:00 12:00
Luncheon SeminarMeiji Seika
Pharma Co., Ltd.
Luncheon SeminarAstellas
Pharma Inc.13:00 13:00
AsCNPSpecial Lecture
Speaker: Hailan Hu
JSNPSpecial Lecture
Speaker: Edward F. Domino
14:00 14:00
AsCNPSpecial Lecture
Speaker: John M. Kane
Herbert Y Meltzer
JSNPSymposium
New vistas on monoamine
contributions to learning and
memorySatoshi Kida
Rethinking of E�ectiveness of
Clozapine Treatment for Treatment-
Refractory Schizophrenia Hidehiro
Oshibuchi
The aging e�ects on the brain,
cognition, and cardiovascular
system of pateints with severe
mental illnessShang-ying Tsai
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
Planning and conducting large pragmatic trials in psychiatry: for e�ective
discovery, dissemination and implementation of
evidence-based practicesMitsuhiko
Yamada
Toward a new era of precision
medicine for Parkinson's
diseaseNobutaka
Hattori
Asian Consortium
on MRI studies in Psychosis
projectKiyoto Kasai
Clinical Experience and Researches of Adult ADHD in
KoreaDuk-In Jon
Epignetic mechanisms underlying psychiatric disordersMakoto
Taniguchi
15:00 15:00
16:00 16:00
PosterDiscussion
17:00 17:00
18:00 18:00
Closing Ceremony
with Farewell Party
19:00 19:00
20:00 20:00
Luncheon Seminar SHIONOGI & CO., LTD. / Takeda Pharmaceutical
Company Limited
E J J E E E J J J
E J
J
E E E E
J
J J
8:40
10:20
12:10
E
E
J E E E J J J14:5014:40
13:40
12:3012:30
13:3013:30
6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) 11
Building Congress Center Congress Center Fukuoka Sunpalace Hotel and Hall Congress Center BuildingFloor 3F 4F 4F 5F 2F 2F FloorVenue Room1 Room2 Room3 Room4 Room5 Room6 Room7 Room8 Room9 Room10 Room11 Room12 Room13 Room14 Room15 Room16 Room17 Poster Session VenueRoom Main Hall 411+412 413+414 409 410 401+402 403 404 405 406 502 503 501 Palace Room A Palace Room B Heian Suehiro Multipurpose Hall Room8:00
Set Up
8:00
JSNP General Assembly
Noteworthy drug discovery/
research and development - Aiming for innovation -
Tetsurou Kikuchi
JSNPSymposium
EGUIDE workshop
Cognitive impairments,
neuroimaging and genetics in chronic methamphetamine users and ketamine
usersYanhui Liao
New development of
Research in Asian Psychotropic
Drug Prescription
(REAP)ChayHoon Tan
The multidimensional
approach to treatment
response in major depression
Po-Hsiu Kuo
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
Sponsored Symposium
Japan Tobacco Inc.
Dementia-In�ammation
and PropagationTetsuaki Arai
Translational Research regarding
pharmacological treatment of
ADHD Masanori Isobe
AsCNPAward Lecture
9:00 9:00
10:00 10:00
JSNP Seminar
CINP Symposium - Current and future
management of major depressive
disorder: challenges and perspectives -
Siegfried Kasper
Sponsored Symposium
Janssen Pharmaceutical
K.K.
Psychostimulant Addiction and
Psychosis: Human Brain Imaging and
Rodent StudiesJin-Chung
Chen
Basic and Translational Research in
EpilepsyZhong Chen
Neuroimmune Mechanisms of Mood Disorder: A Translational
PerspectivePo See Chen
JSNPSymposium
JSNPSymposium
AsCNPOral Session
AsCNPAward Lecture
JSNPSymposium
Sponsored Symposium
Japan Tobacco Inc.
New frontier of bio-
markers and therapeutics in
DementiaKohji
Fukunaga
JSNPSymposium
Multifaceted Roles of Orexins:
Sleep, Pain and Reward Regulations
Lih-Chu Chiou
Poster Exhibition
11:00 11:00
12:00 12:00
Luncheon SeminarMeiji Seika
Pharma Co., Ltd.
Luncheon SeminarAstellas
Pharma Inc.13:00 13:00
AsCNPSpecial Lecture
Speaker: Hailan Hu
JSNPSpecial Lecture
Speaker: Edward F. Domino
14:00 14:00
AsCNPSpecial Lecture
Speaker: John M. Kane
Herbert Y Meltzer
JSNPSymposium
New vistas on monoamine
contributions to learning and
memorySatoshi Kida
Rethinking of E�ectiveness of
Clozapine Treatment for Treatment-
Refractory Schizophrenia Hidehiro
Oshibuchi
The aging e�ects on the brain,
cognition, and cardiovascular
system of pateints with severe
mental illnessShang-ying Tsai
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
JSNPSymposium
Planning and conducting large pragmatic trials in psychiatry: for e�ective
discovery, dissemination and implementation of
evidence-based practicesMitsuhiko
Yamada
Toward a new era of precision
medicine for Parkinson's
diseaseNobutaka
Hattori
Asian Consortium
on MRI studies in Psychosis
projectKiyoto Kasai
Clinical Experience and Researches of Adult ADHD in
KoreaDuk-In Jon
Epignetic mechanisms underlying psychiatric disordersMakoto
Taniguchi
15:00 15:00
16:00 16:00
PosterDiscussion
17:00 17:00
18:00 18:00
Closing Ceremony
with Farewell Party
19:00 19:00
20:00 20:00
Luncheon SeminarTakeda Pharmaceutical Company
Limited / Lundbeck Japan K.K.
Luncheon SeminarMOCHIDA PHARMACEUTICAL CO., LTD. / Mitsubishi Tanabe Pharma Corporation /
Yoshitomiyakuhin Corporation
How should our journals be? ~ Clinical Psychopharmacology and Neuroscience &
Neuropsychopharmacology Reports ~
Duk-In JonTsuyoshi Miyakawa
AsCNP Session JSNP/JSCNP Session JSNP Session JSCNP Session Sponsored Session
J : Japanese E : English
J J
J
J E
J
E E
E
J
J E J
JJJ
E E
J J J E
E
E E E E
14:40
13:40
10:10
16:40
18:1018:20
12:30
8:20
13:30
Asian College of Neuropsychopharmacology
Abstract Submission
Late-breaking Abstract Submission: July 1 (Mon) – 31 (Wed), 2019
Information
• Late-breaking abstracts will be published only on the website and will not be included in the abstract booklet.
• Presentation style for late-breaking abstracts is poster presentation only. (Late-breaking abstracts will not be selected for oral presentations.)
• First authors of late-breaking abstracts should be AsCNP members. Please see and check your AsCNP membership in the AsCNP homepage. When the first author is not an AsCNP member, please become an AsCNP member.
【AsCNP Homepage】http://ascnp.org/membership/index.html
• First authors of accepted abstracts should make a presentation in the poster sessions which are organized by chairs.
• First authors should be presenting authors and registered participants. Only abstracts submitted by first authors who have registered and paid their registration fees will be accepted.
Website Information
【AsCNP2019 Website】https://www2.aeplan.co.jp/ascnp/
【Hotel Reservation Website】https://www.tabikobo.com/corporate/mice/
ascnp2019/en/
【JSNP2019 Website】https://www2.aeplan.co.jp/jsnp/
【JSCNP2019 Website】https://www2.aeplan.co.jp/jscnp/
12 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)
Neuropsychopharmacology to the next generation:New wave from Asia
Registration
Registration Type
Rates
Early Bird *** Registration
January - July 31
Regular Registration
August 1 - August 30
On-site Registration
Members * JPY 37,000 JPY 40,000 JPY 45,000
Members(Developing Countries) **
JPY 22,000 JPY 25,000 JPY 30,000
Non-members JPY 47,000 JPY 50,000 JPY 55,000
Non-members(Developing Countries) **
JPY 32,000 JPY 35,000 JPY 40,000
Student Members JPY 8,000 JPY 10,000 JPY 15,000
Student Non-members JPY 11,000 JPY 13,000 JPY 18,000
Accompanying Persons JPY 5,000 JPY 5,000 JPY 5,000
Registration Fee for Members, Non-members and Student Members includes:
•Admission to all scientific sessions including Japanese sessions•Admission to Preopening Gathering on October 10 (Thu)•Admission to Opening Ceremony on October 11 (Fri)• Admission to the Joint Social Gathering with the Japanese Society of Neuropsychopharmacology
(JSNP) and the Japanese Society of Clinical Neuropsychopharmacology (JSCNP) on October 11 (Fri).
•Admission to poster exhibition and technical exhibition•Congress materials (Program Booklet, etc.)
Registration Fee for Accompanying Persons includes:
•Admission to Preopening Gathering on October 10 (Thu)•Admission to Opening Ceremony on October 11 (Fri)• Admission to the Joint Social Gathering with the Japanese Society of Neuropsychopharmacology
(JSNP) and the Japanese Society of Clinical Neuropsychopharmacology (JSCNP) on October 11 (Fri).
Registration Cancellation Policy
Registration fees are non-refundable.
6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019) 13
Asian College of Neuropsychopharmacology
Information of Certi�catesEach AsCNP2019 attendee receives the certificate of AsCNP2019 attendance
Information of certificates for Japanese attendees本大会では以下の制度の単位対象となっております(一部予定)。最新情報は JSNP2019または JSCNP2019大会ホームページをご確認ください。申請につきましては、参加証等必要書類を保管の上、各機関へ各自で申請手続きを行ってください。
日本神経学会 専門医制度単位数 大会参加にて 2単位
日本睡眠学会 睡眠医療認定単位数 大会参加にて 2単位
日本精神神経学会 精神科専門医制度(予定)単位数 指定セッション聴講により最大 3単位(ポイント対象学会 B群)会期中に会員カードご提示により、所定の手続きをさせていただきますので、会員カードをご持参ください。
日本薬剤師研修センター 研修認定薬剤師制度(予定)単位数 3単位 /日(最大 9単位)日毎に受講シールを配布させていただきます。
日本病院薬剤師会 1)専門薬剤師・認定薬剤師(予定)単位数 指定セッション聴講により4単位 /日(最大
12単位)日毎に研修単位シールを配布させていただきます。
日本医師会 認定産業医制度(予定)単位数 指定セッション毎に 1単位産業医認定書番号(8桁)をお伺いし、認定シールを配布させていただきます。
2)精神科薬物療法認定薬剤師(予定)単位数 指定セッション毎に 0.75単位講習会受講書を配布させていただきます。申請時には日病薬研修単位シールもあわせて必要になります。
「日本薬剤師研修センター」の受講シールと「日本病院薬剤師会」の研修単位シールの重複発行はできません。
統合失調症薬物治療ガイドライン講習会統合失調症薬物治療ガイドラインに記載されている内容の周知だけでなく、記載されていないものの大切な問題についても紹介し、参加者が統合失調症について知識をより深めるものになることを目的としています。誰でも参加できますので、どなたでもご参加ください。事前参加申込者には、修了証をお渡しいたします。参加費:総会参加者:7,000円、本講習会のみの参加者:12,000円詳細は、JSNP2019及び JSCNP2019ホームページをご確認ください。
臨床精神神経薬理学セミナー臨床精神神経薬理学に関する優れた学識と高度の技術および倫理観を備えた臨床精神神経薬理学専門医を養成し、良質の医療を提供することを目的としています。
対 象:日本臨床精神神経薬理学会会員 ・ 臨床精神神経薬理学専門医申請及び更新を
目指す医師の方 ・生涯学習の一環として受講を希望される方研修単位:専門医更新のための単位(10単位)受 講 料:臨床精神神経薬理学専門医 5,000円 上記以外 10,000円
臨床試験 - 倫理教育セミナー精神神経用剤(向精神薬)の治療を適正に実施するために必要な基礎知識の普及を目的としています。
対 象:日本臨床精神神経薬理学会会員研修単位: 「治験登録医」、「創薬・育薬認定師」更新の
ための単位(4単位)受 講 料:5,000円
詳細は、JSCNP2019ホームページをご確認ください。
14 6th Congress of Asian College of Neuropsychopharmacology (AsCNP2019)
Access
1km
Tenjinkita
Gofukumachi
Chiyo-kenchoguchi
Higashi Park
Yoshizuka
Hako
zaki
Lin
e (F
ukuo
ka C
ity S
ubw
ay)
Nanotsu-dori
Taihaku-dori
SanyoShinkansen
Yoshizuka-dori
KagoshimaMain Line
Kag
osh
ima
Mai
n L
ine
Hotel New Otani
Watanabe-dori
Kokutai Doro
Nishitetsu Tenjin
Omuta Line
ANA CrownePlaza Fukuoka
Grand Hyatt
NishitetsuGrand Hotel
Kuko Line
(Fukuoka City Subway)
Nanakuma Line (Fukuoka City Subway)
Hotel Okura
Kyushu UniversitySchool of Medicine
KyushuShinkansen
Maidashi-Kyudai-byoin-mae
Gofukumachi
Nakasukawabata
AkasakaNishitetsuFukuoka Tenjin
Yakuin-Odori
Yakuin Watanabe-dori
Tenjinminami
Gion
Hakata Hyatt Regency
To FukuokaAirport
Tenjin
Chiyo
Hakataekihigasi
Chidoribashi JCT
Canal CityHakata
Hyaku
nenb
ashi
-dor
i
Fukuoka InternationalCongress Center
Fukuoka Sunpalace Hoteland Hall
Fukuoka International Congress Center / Fukuoka Sunplace Hotel and Hall
Fukuoka International Airport Fukuoka Airport Subway Station
Bus StopJR Hakata Station Hakata-exit City Bank-maeBus Stop FNo.88/ No.99
Bus StopTenjin Solaria Stage-mae Bus Stop2A No.80
【to Hakata Pier.】Get off at Kokusai Center-San Palace-mae
【to Chuou Pier.】Get off at Kokusai kaigijyo-San Palace-mae
No.88
5minutes.by subway
A short walk
11minutes.by busNo.99
15minutes.by subway
A short walk
9minutes.by busNo.80